Phillip Dolamore
Plus aucun poste en cours
Historique de carrière de Phillip Dolamore
Anciens postes connus de Phillip Dolamore
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Glaxo, Inc. | Corporate Officer/Principal | - | - |
| GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - | - |
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Corporate Officer/Principal | 01/01/2008 | - |
Statistiques
Internationale
| Royaume-Uni | 3 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
Sectorielle
| Health Technology | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
| Glaxo, Inc. | |
| GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
- Bourse
- Insiders
- Phillip Dolamore
- Expérience
